Feb 18 (Reuters) - Australian biotech CSL Ltd (CSL) on Thursday reported a 45% rise in half-year profit, boosted by higher demand for its vaccines and blood plasma products.
Net profit after tax came in at $1.81 billion for the six months ended December, up from $1.25 billion last year.
News: CSL Australia's CSL reports 45% jump in half-year profit
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$299.60 |
Change
-1.600(0.53%) |
Mkt cap ! $145.0B | |||
| Open | High | Low | Value | Volume |
| $300.91 | $301.16 | $298.02 | $174.8M | 583.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2000 | $299.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $299.69 | 766 | 1 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| CSL (ASX) Chart |